Abstract

Human fungal pathogens represent a serious and increasing threat to human health. It is widely acknowledged that novel antifungal drugs are urgently needed to deal with the growing problem of fungal diseases, and to that aim a deeper understanding of the infection process is required. Primary metabolism is one fundamental virulence trait of fungal pathogens, as their capacity to assimilate nutrients and to adapt to the conditions of the dynamic mammalian host is central to their ability to colonise human tissues. Therefore, primary metabolism can be considered a broad, promising source for potential antifungal targets. In this chapter we present an in-depth overview of fungal primary metabolism, its known links with fungal virulence and highlight the proposed targets for development of novel antifungal drugs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.